Dare Bioscience files Form 8-K to submit original and supplemental BiomX materials

Dare Bioscience failed to meet the registration deadline for biomX Inc. as a part of its proposed special purpose acquisition company merger; the company has now filed the necessary materials with the SEC and the Bank of Greece to remedy the issue.